×
About 2,205 results

ALLMedicine™ Typhoid Fever Center

Research & Reviews  587 results

A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adj...
https://doi.org/10.1016/j.vaccine.2022.06.043
Vaccine Honda-Okubo Y, Cartee RT et. al.

Jun 25th, 2022 - Typhax is an investigational typhoid fever vaccine candidate that is comprised of Vi polysaccharide from Salmonella enterica serovar typhi (S. Typhi) non-covalently entrapped in a glutaraldehyde catalyzed, cross-linked α-poly-L-lysine and CRM197 p...

Tackling typhoid fever burden in south Asia.
https://doi.org/10.1016/S2214-109X(22)00210-8
The Lancet. Global Health; Basnyat B

Jun 18th, 2022 - Tackling typhoid fever burden in south Asia.|2022|Basnyat B,|epidemiology,epidemiology,prevention & control,

Salmonella Typhi: A Review of Antibiogram Journey in Developing Countries.
https://doi.org/10.2174/1871526522666220609100932
Infectious Disorders Drug Targets; Singhal L, Sandhu D et. al.

Jun 14th, 2022 - Typhoid fever remains a major global health problem in low-and middle-income countries. It affects millions of children and adults globally each year with high prevalence in South Asia. Up to 1% of patients who get typhoid may die of the disease a...

Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak ...
https://doi.org/10.1016/j.vaccine.2022.04.093
Vaccine Lightowler MS, Manangazira P et. al.

Jun 12th, 2022 - Zimbabwe suffers from regular outbreaks of typhoid fever (TF), worse since 2017. Most cases were in Harare and a vaccination campaign with Typhoid Conjugate Vaccine (TCV) was conducted in March 2019. The vaccine effectiveness (VE) was assessed aga...

Rainfall Anomalies and Typhoid Fever in Blantyre, Malawi.
https://doi.org/10.1017/S0950268822000759
Epidemiology and Infection; Gauld JS, Bilima S et. al.

May 11th, 2022 - Rainfall Anomalies and Typhoid Fever in Blantyre, Malawi.|2022|Gauld JS,Bilima S,Diggle PJ,Feasey NA,Read JM,|

see more →

Drugs  202 results see all →

Clinicaltrials.gov  37 results

CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera
https://clinicaltrials.gov/ct2/show/NCT03705585

May 4th, 2022 - This is an open-label, non-randomized study. The purpose of this study is to better understand how vaccines against typhoid fever and cholera affect the normal immune system and bacteria in the intestine. Patients having standard-of-care endoscopi...

Persistent Readiness Through Early Prediction Immunization Study
https://clinicaltrials.gov/ct2/show/NCT05346302

Apr 26th, 2022 - The objective of the study is to collect data from participants for a period of 4 weeks. These data will be used for developing and testing an algorithm for early detection of infection. At the end of week two, subjects will receive an immunizatio...

Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction
https://clinicaltrials.gov/ct2/show/NCT02868970

Mar 11th, 2022 - Although there are many safe and effective vaccines for adults, the Public Health Agency of Canada has noted that public perception of vaccination is that it is primarily for infants and children. The National Advisory Committee on Immunization (N...

WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
https://clinicaltrials.gov/ct2/show/NCT04543877

Mar 2nd, 2022 - Inulin, a dietary fiber supplement, is known to increase gut levels of potentially beneficial bacteria, including Bifidobacterium that are indigenous to gut microbiomes. Our underlying hypothesis is that the commensal microbiome, including Bifidob...

Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi
https://clinicaltrials.gov/ct2/show/NCT03299426

Feb 16th, 2022 - This study is a double-blind, individually randomized, controlled, clinical efficacy trial with two vaccine groups: Vi-TCV (Typhoid conjugate) and MCV-A (meningococcal group A conjugate). This study will take place in Blantyre, Malawi, Africa. Par...

see more →

News  49 results

Typhoid Fever Bacteria Becoming More Resistant to Antibiotics
https://www.medscape.com/viewarticle/976136

Jun 23rd, 2022 - Bacteria that cause typhoid fever are becoming increasingly resistant to common antibiotics worldwide, a new analysis indicates. Resistant strains of Salmonella enterica serovar Typhi (S Typhi) — almost all originating in South Asia — have spread ...

I Am CDC - Nelly Mejia
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/415953

I’m an economist in CDC’s Center for Global Health. My general interest in economics started when I was a child and wanted to fight poverty. I got interested in health when I was getting my PhD from Rand and got involved in studies that us...

Single-Dose Typhoid Vaccine 84% Effective in Africa Trial
https://www.medscape.com/viewarticle/958831

Sep 16th, 2021 - NEW YORK (Reuters Health) - A single dose of the Vi-TCV typhoid fever vaccine was more than 80% effective in a test of 28,130 Malawian children aged nine months to 12 years, according to new research. There were 46.9 confirmed cases of typhoid per...

A Man With Fever, Fatigue, and a Trip to Nigeria
https://www.medscape.com/viewarticle/946721

Mar 4th, 2021 - A 36-year-old African man who immigrated to the United States 10 years ago presents to the emergency department (ED) complaining of fever, fatigue, headache, muscle aches, and occasional nausea and vomiting for the past 5 days. He reports no chron...

CDC Warns of Drug-Resistant Typhoid Fever Outbreak
https://www.medscape.com/viewarticle/945986

Feb 17th, 2021 - A new drug-resistant strain of Salmonella Typhi has infected at least 71 people in the United States, according to the Centers for Disease Control and Prevention. The new strain, extensively drug-resistant (XDR) Typhi, caused a large outbreak in P...

see more →

Patient Education  7 results see all →